科学研究 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial Infarction
Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock
Healed Culprit Plaques in Patients With Acute Coronary Syndromes
Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference
Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

Original Research

2021 Jan 13.

JOURNAL：Circulation.

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial

GG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.

16836

Keywords: PCSK9 inhibition; lipoprotein(a)

Full Text PDF